JP2005081124A - Drug container, its manufacturing method, and drug mixing apparatus - Google Patents

Drug container, its manufacturing method, and drug mixing apparatus Download PDF

Info

Publication number
JP2005081124A
JP2005081124A JP2003358482A JP2003358482A JP2005081124A JP 2005081124 A JP2005081124 A JP 2005081124A JP 2003358482 A JP2003358482 A JP 2003358482A JP 2003358482 A JP2003358482 A JP 2003358482A JP 2005081124 A JP2005081124 A JP 2005081124A
Authority
JP
Japan
Prior art keywords
connection
drug
drug container
container
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003358482A
Other languages
Japanese (ja)
Inventor
Yutaka Matsuzawa
豊 松澤
Koji Kawahara
幸司 川原
Takashi Morimura
孝史 森村
Tatsuo Suzuki
龍夫 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fukoku Co Ltd
Fukoku KK
Original Assignee
Fukoku Co Ltd
Fukoku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fukoku Co Ltd, Fukoku KK filed Critical Fukoku Co Ltd
Priority to JP2003358482A priority Critical patent/JP2005081124A/en
Publication of JP2005081124A publication Critical patent/JP2005081124A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Package Specialized In Special Use (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Blow-Moulding Or Thermoforming Of Plastics Or The Like (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a drug container capable of aseptically mixing drug with dissolved/diluted solution at minimized cost when the drug in the container is not heat-resistant, which does not require a part of a connecting member such as a packing or the like to be fixed to itself when a vial as the drug container and a solution container such as a flexible one or the like are connected and enables to maintain cleanliness and asepsis in a connecting part without a cap made of other member. <P>SOLUTION: The drug container 1 includes a connecting means 10 to mix the drug in a main body 2 with solution when it is used. Immediately after the main body 2 is formed of a thermoplastic resin, drug is filled therein. Soon after that, the connecting means 10 is mounted on an opening 5 of the main body 2 and a part of the thermoplastic resin is welded on the connecting means 10 so as to seal the opening 5 of the main body 2 and the connecting means 10 with a resin cap 7 made of the thermoplastic resin. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、薬液と溶解液あるいは希釈液等の液剤を使用直前に混合するための薬剤混合装置並びにこの薬剤混合装置を構成する薬剤容器として好適な薬剤容器及びその製造方法に関するものである。  The present invention relates to a drug mixing device for mixing a drug solution and a solution such as a dissolution solution or a diluting solution immediately before use, a drug container suitable as a drug container constituting the drug mixing device, and a method for manufacturing the same.

点滴注射に用いられている薬剤混合装置としては、薬剤を収容する薬剤容器と溶解液あるいは希釈液等を収容する液剤容器とを有し、点滴使用の直前に液剤容器内に設けられた連通針が薬剤容器の栓体を破ることにより、連通針を介して液剤と薬剤とを混合させるようにした薬剤混合装置が開発されている。
この薬剤混合装置の一例として、薬剤容器としてのバイアルと、液剤容器としての可撓性容器とが接続部材により予め接続されており、可撓性容器に設けられた連通針をバイアル側に移動させることによって点滴使用直前にバイアルの栓体を破るようにした薬剤混合装置が知られている(例えば、特許文献1参照。)。
The drug mixing device used for the drip injection has a drug container for storing the drug and a liquid drug container for storing a solution or a diluent, and a communicating needle provided in the liquid drug container immediately before the drip use However, a drug mixing device has been developed in which a liquid and a drug are mixed through a communicating needle by breaking the plug of the drug container.
As an example of this medicine mixing device, a vial as a medicine container and a flexible container as a liquid medicine container are connected in advance by a connecting member, and a communication needle provided in the flexible container is moved to the vial side. Thus, there is known a drug mixing device that breaks the stopper of a vial immediately before use of an infusion (see, for example, Patent Document 1).

特開平6−254136号公報(第2−4頁、図1、図2)JP-A-6-254136 (page 2-4, FIGS. 1 and 2)

しかしながら、上述した従来の薬剤混合装置においては、薬剤容器としてのバイアルと液剤容器としての可撓性容器とを接続する際に、可撓性容器に設けられた接続ポートと液密に嵌合する接続パッキンなどの接続部材の一部を薬剤容器へ別途組み付けが必要になるという欠点があった。  However, in the conventional drug mixing apparatus described above, when connecting a vial as a drug container and a flexible container as a liquid drug container, the connection port provided in the flexible container fits in a liquid-tight manner. There is a drawback that a part of the connection member such as the connection packing needs to be separately assembled to the medicine container.

また、薬剤容器に充填する薬剤がオートクレーブ滅菌できない耐熱性のない薬液である場合、薬剤容器に無菌充填する際に薬剤容器を予め滅菌しなければならず、薬剤容器がガラス製のバイアルであれば従来行われている無菌充填ライン上で乾熱滅菌すればよいが、薬剤容器が樹脂製のバイアルの場合、耐熱性がないので乾熱滅菌できず、予め別の方法で滅菌されたバイアルを準備しなければならなかった。  In addition, if the drug to be filled in the drug container is a non-heat-resistant chemical solution that cannot be autoclaved, the drug container must be sterilized before filling the drug container aseptically, and if the drug container is a glass vial, It is only necessary to perform dry heat sterilization on a conventional aseptic filling line. However, if the drug container is a resin vial, it cannot be dry heat sterilized because it has no heat resistance, and a vial previously sterilized by another method is prepared. Had to do.

このように、薬剤容器に充填する薬剤が耐熱性のない薬液である場合、ガラス製のバイアルを用いれば、従来の無菌充填装置を用いることができるので比較的低コストでの製品化が可能であるが、ガラス製のバイアルとその他のプラスチック部材を分離して分別廃棄しなければならず、一方、分別廃棄の煩雑性を回避するために樹脂製のバイアルを用いた場合は、上述の理由により従来の無菌充填装置を用いることができず無菌充填が非常に困難になるため、コストアップを招くという欠点があった。  In this way, when the drug to be filled in the drug container is a non-heat-resistant drug solution, if a glass vial is used, a conventional aseptic filling device can be used, so that it can be commercialized at a relatively low cost. However, glass vials and other plastic parts must be separated and disposed of separately. On the other hand, if resin vials are used to avoid the complexity of separation and disposal, for the reasons described above. Since the conventional aseptic filling apparatus cannot be used and aseptic filling becomes very difficult, there is a disadvantage that the cost is increased.

そこで、本願発明者らは、上記問題点を解決するために特願2003−203344号明細書に示すように、薬剤容器としてのバイアルと可撓性容器等の液剤容器とを接続する際に、接続パッキンなどの接続部材の一部を薬剤容器へ別途組み付ける必要がなく、また、薬剤容器に充填する薬剤が耐熱性のない薬液であっても、コストアップをできる限り抑えつつ、溶解液や希釈液と無菌的に混合し得るようにした薬剤混合装置並びにこの薬剤混合装置用として好適な薬剤容器及びその製造方法を提案している。  Therefore, the inventors of the present application, as shown in Japanese Patent Application No. 2003-203344, in order to solve the above problems, when connecting a vial as a drug container and a liquid drug container such as a flexible container, It is not necessary to assemble part of the connection member such as connection packing into the drug container, and even if the drug to be filled in the drug container is a non-heat-resistant chemical solution, it is possible to dissolve and dilute while suppressing cost increase as much as possible. A drug mixing device that can be aseptically mixed with a liquid, a drug container suitable for the drug mixing device, and a method for manufacturing the same are proposed.

上記の特願2003−203344号明細書に開示した薬剤容器は、従来技術の問題点を十分に改良したものであるが、この薬剤容器と液剤容器を無菌状態で嵌合固定するときに、薬剤容器の接続部分を嵌合直前に滅菌処理をする必要があった。また、薬剤容器の接続部分は開放になっているために、汚染防止のためには別にキャップを成型して開放部分を覆う必要があった。  The drug container disclosed in the above-mentioned Japanese Patent Application No. 2003-203344 is a sufficiently improved problem of the prior art. When this drug container and the liquid drug container are fitted and fixed in an aseptic condition, the drug container It was necessary to sterilize the connecting portion of the container immediately before fitting. Further, since the connecting portion of the medicine container is open, it is necessary to form a cap separately to cover the open portion in order to prevent contamination.

そこで、本発明は、薬剤容器としてのバイアルと可撓性容器等の液剤容器とを接続する際に、接続パッキンなどの接続部材の一部を薬剤容器へ別途組み付ける必要がなく、さらに、別部材のキャップを必要としないで接続部の清浄度と無菌状態を維持でき、また、薬剤容器に充填する薬剤が耐熱性のない薬液であっても、コストアップをできる限り抑えつつ、溶解液や希釈液と無菌的に混合し得るようにした薬剤混合装置並びにこの薬剤混合装置用として好適な薬剤容器及びその製造方法を提供することを目的とする。  Therefore, the present invention eliminates the need for separately assembling a part of a connection member such as a connection packing to the drug container when connecting a vial as a drug container and a liquid drug container such as a flexible container. It is possible to maintain the cleanliness and sterility of the connection part without the need for a cap, and even if the drug filled in the drug container is a non-heat-resistant drug solution, the solution and dilution can be reduced while minimizing the cost increase. It is an object of the present invention to provide a drug mixing apparatus that can be aseptically mixed with a liquid, a drug container suitable for the drug mixing apparatus, and a method for manufacturing the same.

本発明の請求項1に係る薬剤容器は、使用時に薬剤容器本体内に収容された薬剤を液剤と混合するための接続手段を有する薬剤容器において、熱可塑性樹脂の成形により前記薬剤容器本体が形成され、前記薬剤容器本体の形成直後に前記薬剤容器本体内に薬剤が充填され、前記薬剤の充填直後に前記薬剤容器本体の開口部に前記接続手段を配設し、前記熱可塑性樹脂の一部を前記接続手段に溶着して前記薬剤容器本体の開口部を密閉するとともに、前記接続手段を前記熱可塑性樹脂の一部から構成される樹脂キャップで密封したことを特徴とする。  The drug container according to claim 1 of the present invention is a drug container having connection means for mixing the drug contained in the drug container main body with the liquid at the time of use, wherein the drug container main body is formed by molding a thermoplastic resin. Immediately after the formation of the drug container body, the drug container body is filled with a drug, and immediately after the drug is filled, the connecting means is disposed in the opening of the drug container body, and a part of the thermoplastic resin Is welded to the connecting means to seal the opening of the drug container body, and the connecting means is sealed with a resin cap formed of a part of the thermoplastic resin.

本発明の請求項2に係る薬剤容器は、請求項1に係る薬剤容器において、前記接続手段は、保管時に前記薬剤容器本体を密閉する蓋体と、液剤容器の接続ポートが液密に嵌合する接続体とを有することを特徴とする。  The drug container according to claim 2 of the present invention is the drug container according to claim 1, wherein the connecting means is a liquid-tight fit between a lid that seals the drug container main body during storage and a connection port of the liquid drug container And a connecting body.

本発明の請求項3に係る薬剤容器は、請求項2に係る薬剤容器において、前記蓋体と前記接続体とが同一部材からなることを特徴とする。  The medicine container according to claim 3 of the present invention is characterized in that, in the medicine container according to claim 2, the lid body and the connection body are made of the same member.

本発明の請求項4に係る薬剤容器は、請求項2又は3に係る薬剤容器において、前記接続手段は、一端側に前記蓋体と前記接続体が収容され、他端側に前記接続ポートが挿入される接続筒を有することを特徴とする。  The drug container according to a fourth aspect of the present invention is the drug container according to the second or third aspect, wherein the connecting means is configured such that the lid and the connection body are accommodated at one end side, and the connection port is disposed at the other end side. It has the connection cylinder inserted.

本発明の請求項5に係る薬剤容器は、請求項4に係る薬剤容器において、前記蓋体、前記接続体及び前記接続筒とが予め一体化されており、前記熱可塑性樹脂の一部は前記接続筒に溶着していることを特徴とする。  The drug container according to claim 5 of the present invention is the drug container according to claim 4, wherein the lid, the connection body, and the connection tube are integrated in advance, and a part of the thermoplastic resin is the It is characterized by being welded to the connecting tube.

本発明の請求項6に係る薬剤容器は、請求項4又は5に係る薬剤容器において、前記接続ポートの先端部と前記接続体とが同軸的に嵌合し、前記接続ポートの基端部と前記接続筒とが同軸的に嵌合し、前記接続体の内径が前記接続筒の内径よりも小さいことを特徴とする。  The drug container according to claim 6 of the present invention is the drug container according to claim 4 or 5, wherein the distal end portion of the connection port and the connection body are fitted coaxially, and the proximal end portion of the connection port The connection tube is coaxially fitted, and the inner diameter of the connection body is smaller than the inner diameter of the connection tube.

本発明の請求項7に係る薬剤容器は、請求項4乃至6のいずれか一に係る薬剤容器において、前記接続筒の内周面と前記接続ポートの基端部外周面とに相互に係合する係合手段を設けたことを特徴とする。  A drug container according to a seventh aspect of the present invention is the drug container according to any one of the fourth to sixth aspects, wherein the inner peripheral surface of the connection tube and the outer peripheral surface of the proximal end portion of the connection port are engaged with each other. It is characterized in that an engaging means is provided.

本発明の請求項8に係る薬剤容器は、請求項7に係る薬剤容器において、前記係合手段は、一方が爪部で他方が孔部であることを特徴とする。  The drug container according to claim 8 of the present invention is the drug container according to claim 7, characterized in that one of the engaging means is a claw portion and the other is a hole portion.

本発明の請求項9に係る薬剤容器は、請求項1乃至8のいずれか一に係る薬剤容器において、前記薬剤容器本体の非開口部に懸垂口部を設けたことを特徴とする。  A drug container according to a ninth aspect of the present invention is characterized in that, in the drug container according to any one of the first to eighth aspects, a suspension opening is provided in a non-opening portion of the drug container body.

本発明の請求項10に係る薬剤容器の製造方法は、使用時に薬剤容器本体内に収容された薬剤を液剤と混合するための接続手段を有する薬剤容器の製造方法において、
熱可塑性樹脂をブロー成形又は真空成形して前記薬剤容器本体を形成する第1の工程と、
前記ブロー成形又は真空成形直後に前記薬剤容器本体内に薬剤を充填する第2の工程と、
前記薬液の充填直後に前記薬剤容器本体の開口部に前記接続手段を配設する第3の工程と、
前記熱可塑性樹脂の一部を前記接続手段に溶着して前記薬剤容器本体の開口部を密閉する第4の工程と、
前記熱可塑性樹脂の一部を前記接続手段を覆うようにして樹脂キャップを形成する第5の工程と、
を備えたことを特徴とする。
The method for producing a drug container according to claim 10 of the present invention is a method for producing a drug container having connection means for mixing the drug contained in the drug container main body with a liquid agent at the time of use.
A first step of blow molding or vacuum forming a thermoplastic resin to form the drug container body;
A second step of filling the drug container body with a drug immediately after the blow molding or vacuum molding;
A third step of disposing the connecting means at the opening of the drug container body immediately after filling the drug solution;
A fourth step of welding a part of the thermoplastic resin to the connecting means and sealing the opening of the drug container body;
A fifth step of forming a resin cap so that a part of the thermoplastic resin covers the connecting means;
It is provided with.

本発明の請求項11に係る薬剤容器の製造方法は、請求項10に係る薬剤容器の製造方法において、前記接続手段は、前記薬剤容器本体を密閉する蓋体と、液剤容器の接続ポートが液密に嵌合する接続体と、前記接続ポートが挿入される接続筒とを有し、前記蓋体、前記接続体及び前記接続筒とが予め一体化されているとともに、前記熱可塑性樹脂の一部は前記接続筒に溶着していることを特徴とする。  The method for manufacturing a drug container according to claim 11 of the present invention is the method for manufacturing a drug container according to claim 10, wherein the connection means includes a lid for sealing the drug container body and a connection port of the liquid drug container. A connection body that is closely fitted; and a connection cylinder into which the connection port is inserted. The lid body, the connection body, and the connection cylinder are integrated in advance, and one of the thermoplastic resins The portion is welded to the connecting tube.

本発明の請求項12に係る薬剤混合装置は、熱可塑性樹脂の成形により形成される薬剤容器本体を有し、前記薬剤容器本体の形成直後に前記薬剤容器本体内に薬剤が充填され、前記薬剤の充填直後に前記薬剤容器本体の開口部に第1の接続手段を配設し、前記熱可塑性樹脂の一部を前記第1の接続手段に溶着して前記薬剤容器本体の開口部を密閉するとともに、前記熱可塑性樹脂の一部で構成される樹脂キャップで前記第1の接続手段を密封してなる薬剤容器と、
連結直前に前記樹脂キャップが除去された前記第1の接続手段と接続される第2の接続手段を有し、液剤容器本体内に液剤が収容された液剤容器とを備え、
使用時に前記第1の接続手段と前記第2の接続手段とを介して前記薬剤容器本体内と前記液剤容器本体内とが連通可能となるように構成したことを特徴とする。
A drug mixing device according to claim 12 of the present invention has a drug container body formed by molding a thermoplastic resin, and the drug container body is filled with a drug immediately after the drug container body is formed, Immediately after filling, the first connecting means is disposed in the opening of the drug container body, and a part of the thermoplastic resin is welded to the first connecting means to seal the opening of the drug container body. And a medicine container formed by sealing the first connecting means with a resin cap formed of a part of the thermoplastic resin,
Having a second connection means connected to the first connection means from which the resin cap has been removed immediately before connection, and a liquid agent container containing a liquid agent in a liquid agent container body,
In use, the medicine container main body and the liquid container main body can be communicated with each other via the first connecting means and the second connecting means.

本発明の請求項13に係る薬剤混合装置は、請求項12に係る薬剤混合装置において、前記第1の接続手段は、前記薬剤容器本体を密閉する蓋体と、前記第2の接続手段を構成する接続ポートが液密に嵌合する接続体と、一端側に前記蓋体と前記接続体とが収容され、他端側に前記接続ポートが挿入される接続筒とを有し、
前記第2の接続手段は、前記接続ポートと、前記接続ポートに設けられ、前記液剤容器本体内を外部と遮蔽する隔膜と、前記接続ポート内に配設され、内部に軸方向の液体流路が形成された連通針とを有し、
前記連通針は、保管時にその先端が前記隔膜と離間した位置に保持され、使用時にその先端が前記隔膜及び前記蓋体を穿通する位置まで移動可能とされ、前記連通針の前記液体流路を介して前記薬剤が前記液剤容器本体内に流入可能とされていることを特徴とする。
A drug mixing device according to a thirteenth aspect of the present invention is the drug mixing device according to the twelfth aspect, wherein the first connection means includes a lid for sealing the drug container body and the second connection means. A connection body in which the connection port is liquid-tightly fitted, and the connection body in which the lid body and the connection body are accommodated on one end side and the connection port is inserted on the other end side,
The second connection means is provided in the connection port, a diaphragm provided in the connection port and shields the inside of the liquid container body from the outside, and disposed in the connection port, and an axial liquid flow path therein. And a communication needle formed,
The communicating needle is held at a position where the tip is separated from the diaphragm during storage, and the tip is movable to a position where it penetrates the diaphragm and the lid during use, and the communicating needle passes through the liquid flow path of the communicating needle. Thus, the medicine can flow into the liquid container body.

以上説明したように、本発明に係る薬剤容器やその製造方法によれば、薬剤容器本体の形成直後に薬剤容器本体内に薬剤が充填されるため、薬剤容器に薬剤を無菌充填する場合であっても、薬剤容器を予め滅菌する必要がなく、また、薬剤の充填直後に薬剤容器本体の開口部に接続手段を配設するとともに、薬剤容器本体を形成する熱可塑性樹脂の一部を接続手段に溶着して薬剤容器本体の開口部を密閉するため、薬剤の無菌充填を容易に行うことが可能となり、更に接続手段を覆うようにして樹脂キャップが形成されているので、樹脂キャップを取り外すまでは接続手段が無菌状態に保たれているので無菌接続が確実でかつ容易に行うことができる。  As described above, according to the drug container and the manufacturing method thereof according to the present invention, the drug container body is filled with the drug immediately after the drug container body is formed. However, it is not necessary to sterilize the drug container in advance, and the connecting means is disposed at the opening of the drug container body immediately after the filling of the drug, and a part of the thermoplastic resin forming the drug container body is connected to the connecting means. Since the opening of the drug container main body is sealed by welding, it becomes possible to easily perform aseptic filling of the drug, and since the resin cap is formed so as to cover the connecting means, until the resin cap is removed Since the connection means is maintained in a sterile state, the sterile connection can be reliably and easily performed.

また、接続手段としての接続ポートと接続体とが液密に嵌合するため、薬剤容器本体から液剤容器本体へ薬剤を流入させる際の薬剤の液漏れを防止することができる。
また、薬剤容器本体を密閉する蓋体と液剤容器の接続ポートが嵌合する接続体とを同一部材から構成することにより、接続手段の組立てが容易となる。
また、蓋体と接続体が収容された接続筒の他端側に接続ポートが挿入されるように構成することにより、薬剤容器と液剤容器との接続を容易に行うことができる。
In addition, since the connection port as the connection means and the connection body are liquid-tightly fitted, it is possible to prevent the drug from leaking when the drug is allowed to flow from the drug container main body into the liquid drug container main body.
Moreover, the assembly of the connection means is facilitated by configuring the lid for sealing the drug container body and the connection body into which the connection port of the liquid drug container is fitted from the same member.
In addition, by connecting the connection port to the other end of the connection cylinder in which the lid body and the connection body are accommodated, the drug container and the liquid container can be easily connected.

また、接続手段を構成する、蓋体、接続体及び接続筒とを予め組み立てて一体化しておき、さらに、薬剤容器本体を形成する熱可塑性樹脂の一部を接続筒に溶着して接続手段を取付けるようにしたため、薬剤容器本体への接続手段の取付けを極めて容易に、かつ、瞬時に行うことができる。  Further, the lid, the connecting body, and the connecting cylinder constituting the connecting means are assembled and integrated in advance, and a part of the thermoplastic resin forming the drug container body is welded to the connecting cylinder to connect the connecting means. Since it is attached, the attachment of the connecting means to the medicine container body can be performed very easily and instantaneously.

また、接続ポートの先端部と接続体とが同軸的に嵌合し、接続ポートの基端部と接続筒とが同軸的に嵌合するようにしたため、薬剤容器と液剤容器との接続が確実なものになるとともに、接続ポートと接続筒とを略直線状に一体化することができる。
また、接続筒の内周面と接続ポートの基端部外周面とに相互に係合する係合手段を設けたため、接続筒と接続ポートとの接続を確実なものにすることができる。
また、薬剤容器本体の非開口部側に懸垂口部を設けたため、点滴等の薬剤投与の際に薬剤混合装置の吊下げが容易に可能となる。
In addition, the distal end of the connection port and the connection body are fitted coaxially, and the proximal end of the connection port and the connection tube are fitted coaxially, so that the connection between the drug container and the liquid container is ensured. In addition, the connection port and the connection cylinder can be integrated in a substantially straight line.
Further, since the engaging means that engages the inner peripheral surface of the connection tube and the outer peripheral surface of the base end portion of the connection port is provided, the connection between the connection tube and the connection port can be ensured.
In addition, since the suspension opening is provided on the non-opening side of the drug container main body, the drug mixing device can be easily suspended when administering a drug such as an infusion.

そして、本発明による薬剤が無菌充填された薬剤容器と例えばオートクレーブ滅菌により無菌状態が維持されている液剤容器とを無菌接続することができるので、従来の設備を応用することにより、製造が容易で、かつ、安価な薬剤混合装置を得ることができる。  And since the drug container aseptically filled with the drug according to the present invention and a liquid drug container maintained in a sterilized state by autoclave sterilization, for example, can be aseptically connected. In addition, an inexpensive drug mixing device can be obtained.

以下、本発明の実施の形態を図面に基づいて詳細に説明する。図1は本発明の一実施の形態に係る薬剤容器の全体を示す平面図、図2は図1に示す薬剤容器の部分断面図、図3(a)乃至(e)は図1に示す薬剤容器の製造工程を示す部分断面図である。
図1及び図2に示すように、薬剤容器1は、薬剤容器本体2と、後述する第2の接続手段と液密に接続される第1の接続手段(以下、「接続口組立体」と称す。)10と、懸垂口部3から構成されている。
Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings. 1 is a plan view showing the entirety of a medicine container according to an embodiment of the present invention, FIG. 2 is a partial sectional view of the medicine container shown in FIG. 1, and FIGS. 3 (a) to 3 (e) are medicines shown in FIG. It is a fragmentary sectional view which shows the manufacturing process of a container.
As shown in FIGS. 1 and 2, the drug container 1 includes a drug container body 2 and first connection means (hereinafter referred to as “connection port assembly”) that is liquid-tightly connected to second connection means described later. 10) and the suspension port portion 3.

薬剤容器本体2は、低密度ポリエチレン樹脂、直鎖状低密度ポリエチレン樹脂、高密度ポリエチレン樹脂、ポリプロピレン樹脂、軟質ポリエステル樹脂、塩素化ポリエチレン樹脂、エチレン−酢酸ビニル共重合体などの可撓性に富んだ熱可塑性樹脂により形成されおり、その内部には抗生物質や抗菌剤や治療薬剤や反応しやすい成分を分離した輸液剤等の薬液が無菌状態で収容されている。  The drug container body 2 is rich in flexibility such as low density polyethylene resin, linear low density polyethylene resin, high density polyethylene resin, polypropylene resin, soft polyester resin, chlorinated polyethylene resin, ethylene-vinyl acetate copolymer, etc. It is made of a thermoplastic resin and contains liquid medicine such as antibiotics, antibacterial agents, therapeutic drugs, and infusions from which easily reactable components are separated.

薬剤容器本体2の開口端には接続口組立体10が液密に取付けられており、これにより薬剤容器本体2に収容された薬液を密封しており、接続口組立体10は、薬剤容器本体2の一端から延出した熱可塑性樹脂からなる固定部4の熱溶着により薬剤容器本体2と一体化されている。
さらに、固定部4から延出した熱可塑性樹脂を接続口組立体10を完全に覆うように樹脂キャップ7が一体的に形成されている。
A connection port assembly 10 is liquid-tightly attached to the open end of the drug container body 2, thereby sealing the drug solution contained in the drug container body 2. 2 is integrated with the medicine container body 2 by heat welding of a fixing portion 4 made of a thermoplastic resin extending from one end.
Further, a resin cap 7 is integrally formed so as to completely cover the connection port assembly 10 with the thermoplastic resin extending from the fixing portion 4.

図2に示すように、接続口組立体10は、保管時に薬剤容器本体2を密閉する内キャップ11と、後述する第2の接続手段を構成する接続ポートの先端部と液密にかつ同軸的に嵌合する接続パッキン12と、前記接続ポートの基端部と同軸的に嵌合する小径部13aを有する接続筒13を備えて構成されており、内キャップ11と接続パッキン12は、接続筒13の大径部13bに嵌合又は接着等により固着され、内キャップ11、接続パッキン12及び接続筒13は、薬剤容器本体2の開口端への取付前に予め組み立てられて一体化されている。  As shown in FIG. 2, the connection port assembly 10 is liquid-tight and coaxial with the inner cap 11 that seals the drug container body 2 during storage, and the distal end of the connection port that constitutes the second connection means described later. And a connection cylinder 13 having a small-diameter portion 13a that is coaxially fitted to the base end portion of the connection port, and the inner cap 11 and the connection packing 12 are connected to the connection cylinder. The inner cap 11, the connection packing 12, and the connection cylinder 13 are assembled and integrated in advance before being attached to the open end of the drug container body 2. .

また、接続筒13の小径部13aの内周面には、後述する爪部と係合する孔部14が形成されており、また、接続パッキン12の内径は、接続筒13の小径部13aの内径よりも小さく形成されている。
尚、固定部4は、接続筒13の外周面に熱溶着されており、また、固定部4の先端部4aは、接続筒13の段部13cを覆う位置まで延出して接続口組立体10の取付けを確実なものとしている。
Further, a hole portion 14 that engages with a claw portion to be described later is formed on the inner peripheral surface of the small diameter portion 13 a of the connection cylinder 13, and the inner diameter of the connection packing 12 is that of the small diameter portion 13 a of the connection cylinder 13. It is formed smaller than the inner diameter.
The fixing portion 4 is thermally welded to the outer peripheral surface of the connection tube 13, and the tip portion 4 a of the fixing portion 4 extends to a position covering the step portion 13 c of the connection tube 13 and is connected to the connection port assembly 10. The installation of the is ensured.

次に、本実施の形態に係る薬剤容器1の製造方法を、図3に基づいて説明する。薬剤容器1は薬液同時充填中空成形法にて製造される。
以下、これについて詳細に説明する。
まず、熱可塑性樹脂を加熱して溶融し、筒状のパリソンを形成する。そのパリソンを所定の形状を有する中空成形金型100で挟み込み、パリソンの上部開口部5からその内に二重管構造の供給ノズル101の外管から空気を送り込み、中空成形金型100内でパリソンを膨らまして、図3(a)に示すように、薬剤容器本体2と懸垂口部3を形成する。その後直ちに、薬剤容器本体2内に除菌フィルターによってろ過された所定量の薬液を供給ノズル101の内管から無菌充填する。尚、無菌充填とは、日本薬局方に定められた無菌操作法を用いて充填することをいう。
Next, the manufacturing method of the chemical | medical agent container 1 which concerns on this Embodiment is demonstrated based on FIG. The drug container 1 is manufactured by a chemical solution simultaneous filling hollow molding method.
This will be described in detail below.
First, a thermoplastic resin is heated and melted to form a cylindrical parison. The parison is sandwiched between hollow molding dies 100 having a predetermined shape, air is fed from the upper opening portion 5 of the parison into the outer pipe of the supply nozzle 101 having a double tube structure, and the parison is inside the hollow molding dies 100. As shown in FIG. 3A, the medicine container main body 2 and the suspension opening 3 are formed. Immediately thereafter, a predetermined amount of the chemical solution filtered by the sterilization filter is filled in the drug container body 2 aseptically from the inner tube of the supply nozzle 101. Note that aseptic filling means filling using aseptic operation defined by the Japanese Pharmacopoeia.

薬液充填直後に、図3(b)と(c)に示すように、上部開口部5の所定位置に不図示の搬送手段を用いて接続口組立体10を配設する。このとき上部開口部5の熱可塑性樹脂は溶融している状態である。  Immediately after filling with the chemical solution, as shown in FIGS. 3B and 3C, the connection port assembly 10 is disposed at a predetermined position of the upper opening 5 using a conveying means (not shown). At this time, the thermoplastic resin in the upper opening 5 is in a molten state.

次に、図3(d)に示すように、上部開口部5の熱可塑性樹脂が溶融している間に金型102で更に挟みこみ、接続口組立体10に上部開口部5を熱溶着させ、かつその上部を空間を有するように覆って密封して樹脂キャップ7を形成する。その後、金型100,102を開き、薬剤容器1を金型100,102から取り出し、上部開口部5の余分な樹脂6を切除し、図3(e)に示すように薬剤容器1が完成する。尚、中空成形金型100及び金型102は、無菌状態の空間内に配設されている。  Next, as shown in FIG. 3D, the thermoplastic resin in the upper opening 5 is further sandwiched by the mold 102 while the thermoplastic resin is melted, and the upper opening 5 is thermally welded to the connection port assembly 10. Then, the resin cap 7 is formed by covering and sealing the upper portion so as to have a space. Thereafter, the molds 100 and 102 are opened, the drug container 1 is taken out of the molds 100 and 102, and the excess resin 6 in the upper opening 5 is cut away, whereby the drug container 1 is completed as shown in FIG. . The hollow mold 100 and the mold 102 are disposed in a sterile space.

充填する薬剤が熱に弱くオートクレーブ滅菌できないものは、供給ノズル101を含む薬液充填通路を無菌にして無菌充填することが好ましい。充填する薬液が熱に対して安定でオートクレーブ滅菌できるものであれば、通常の充填を行い、充填後、薬剤容器1をオートクレーブつまり高圧蒸気滅菌処理装置により滅菌処理される。
尚、上述した薬剤容器1の製造方法においては、ブロー成形によるものを例示したが、薬剤容器1はブロー成形に限定されず、真空成形にて製造することもできる。
When the medicine to be filled is weak against heat and cannot be sterilized by autoclave, it is preferable to aseptically fill the chemical liquid filling passage including the supply nozzle 101 aseptically. If the chemical solution to be filled is stable against heat and can be sterilized by autoclave, normal filling is performed, and after filling, the drug container 1 is sterilized by an autoclave, that is, a high-pressure steam sterilization apparatus.
In addition, although the thing by blow molding was illustrated in the manufacturing method of the chemical | medical agent container 1 mentioned above, the chemical | medical agent container 1 is not limited to blow molding, It can also manufacture by vacuum forming.

このように本実施の形態に係る薬剤容器1及びその製造方法によれば、薬剤容器本体2の形成直後に薬剤容器本体2内に薬剤が充填されるため、薬剤容器1に薬剤を無菌充填する場合であっても、薬剤容器1を予め滅菌する必要がなく、また、薬剤の充填直後に薬剤容器本体2の上部開口部5に接続口組立体10を配設し、上部開口部5の熱可塑性樹脂が溶融している間に金型102で更に挟みこみ、接続口組立体10に上部開口部5を熱溶着させ、かつその上部を空間を有するように覆って密封して樹脂キャップ7を形成するため、薬剤の無菌充填を容易に行うことが可能になるとともに、薬剤容器本体2への接続口組立体10の取付けも容易に、かつ、接続口組立体10を無菌状態に保つことができる。  As described above, according to the drug container 1 and the manufacturing method thereof according to the present embodiment, the drug container body 2 is filled with the drug immediately after the drug container body 2 is formed, and therefore the drug container 1 is aseptically filled with the drug. Even in this case, it is not necessary to sterilize the drug container 1 in advance, and the connection port assembly 10 is disposed in the upper opening 5 of the drug container main body 2 immediately after filling the drug, and the heat of the upper opening 5 is The plastic cap is further sandwiched between the molds 102 while the plastic resin is melted, the upper opening 5 is thermally welded to the connection port assembly 10, and the upper portion is covered and sealed so as to have a space. Therefore, aseptic filling of the medicine can be easily performed, the attachment of the connection port assembly 10 to the medicine container body 2 can be easily performed, and the connection port assembly 10 can be maintained in a sterile state. it can.

次に、本発明の一実施の形態に係る薬剤混合装置を図面に基づいて詳細に説明する。図4は図1に示す薬剤容器の樹脂キャップを捻じ切ったところを示す平面図、図5は図4に示す薬剤容器を用いた薬剤混合装置の全体を示す平面図、図6は図5に示す薬剤混合装置を構成する可撓性液剤容器の全体を示す平面図、図7は図6に示す可撓性液剤容器の拡大部分断面図である。  Next, a drug mixing device according to an embodiment of the present invention will be described in detail with reference to the drawings. 4 is a plan view showing the resin cap of the medicine container shown in FIG. 1 being twisted, FIG. 5 is a plan view showing the whole medicine mixing apparatus using the medicine container shown in FIG. 4, and FIG. The top view which shows the whole flexible liquid agent container which comprises the chemical | medical agent mixing apparatus shown, FIG. 7 is an expanded partial sectional view of the flexible liquid agent container shown in FIG.

図5に示すように、薬剤混合装置50は、内部に溶解液、希釈液または輸液等液剤が無菌状態で収容される可撓性液剤容器51と、上述した薬剤容器本体2の内部に薬液が無菌状態で収容され、上記の可撓性液剤容器51に接続される図4に示す樹脂キャップ7が捻じ切られた薬剤容器1で構成される。  As shown in FIG. 5, the drug mixing apparatus 50 includes a flexible liquid container 51 in which a solution such as a solution, a diluent, or an infusion is contained in a sterile state, and a drug solution in the drug container body 2 described above. It is comprised by the chemical | medical agent container 1 accommodated in the aseptic state, and the resin cap 7 shown in FIG. 4 connected to said flexible liquid agent container 51 was twisted off.

可撓性液剤容器51の詳細を図6に基づいて説明する。
可撓性液剤容器51は、低密度ポリエチレン樹脂、直鎖状低密度ポリエチレン樹脂、高密度ポリエチレン樹脂、ポリプロピレン樹脂、軟質ポリエステル樹脂、塩素化ポリエチレン樹脂、エチレン−酢酸ビニル共重合体などの可撓性に富んだ材料からなる樹脂フィルムにより形成された液剤容器本体52を有し、この液剤容器本体52の図6における下端部には、内部に薬液吐出通路が貫通して形成された樹脂製の排出口部材53が設けられている。液剤容器本体52内に液剤を充填した後には排出口部材53にゴム栓体58を挿入することにより、薬液吐出通路は閉塞される。
Details of the flexible liquid container 51 will be described with reference to FIG.
The flexible liquid container 51 is made of a flexible material such as a low density polyethylene resin, a linear low density polyethylene resin, a high density polyethylene resin, a polypropylene resin, a soft polyester resin, a chlorinated polyethylene resin, or an ethylene-vinyl acetate copolymer. A liquid container body 52 formed of a resin film made of a rich material, and the lower end of the liquid container body 52 in FIG. An outlet member 53 is provided. After filling the liquid agent container body 52 with the liquid agent, the chemical liquid discharge passage is closed by inserting the rubber plug 58 into the discharge port member 53.

液剤容器本体52の図6における上端部には、第2の接続手段20を構成する樹脂製の連結口部材21が設けられており、この連結口部材21の内部には液剤容器本体52内に連通する連通路が形成され、先端には可撓性液剤容器51の外部との連通路を遮蔽するための隔膜22が設けられている。
また、図6及び図7に示すように、連結口部材21の接続ポート23は円筒状をなし、小径の先端部23aと、大径の基端部23bを有しており、基端部23bの外周面には上述した孔部14と係合する爪部23cが形成されている。
A resin connection port member 21 constituting the second connection means 20 is provided at the upper end portion of the liquid agent container body 52 in FIG. 6, and the connection port member 21 has an inside of the liquid agent container body 52. A communicating path that communicates is formed, and a diaphragm 22 is provided at the tip for shielding the communicating path with the outside of the flexible liquid container 51.
As shown in FIGS. 6 and 7, the connection port 23 of the connection port member 21 has a cylindrical shape, and has a small-diameter distal end portion 23a and a large-diameter proximal end portion 23b, and the proximal end portion 23b. A claw portion 23c that engages with the above-described hole portion 14 is formed on the outer peripheral surface.

連結口部材21の連通路内には合成樹脂製連通針24が軸方向に移動自在に設けられており、この合成樹脂製連通針24は尖った先端部と大径の後端部とを有する。合成樹脂製連通針24の中心部には連通孔24aが形成されており、連通孔24aは合成樹脂製連通針24の先端部の側面から後端部に貫通して形成されている。  A synthetic resin communication needle 24 is provided in the communication path of the connection port member 21 so as to be movable in the axial direction. The synthetic resin communication needle 24 has a pointed tip and a large-diameter rear end. . A communication hole 24 a is formed in the central portion of the synthetic resin communication needle 24, and the communication hole 24 a is formed to penetrate from the side surface of the front end portion of the synthetic resin communication needle 24 to the rear end portion.

また、連結口部材21の後端側には合成樹脂製連通針24を支持する支持スリーブ25が固定されており、この支持スリーブ25には合成樹脂製連通針24の外周面に環状に形成された仮止め部26に係合する凸部27が設けられている。尚、仮止め部26が凸部27に係合している状態では、合成樹脂製連通針24の先端部は隔膜22から離れた位置に保持されるように設定される。  A support sleeve 25 for supporting the synthetic resin communication needle 24 is fixed to the rear end side of the connection port member 21. The support sleeve 25 is formed in an annular shape on the outer peripheral surface of the synthetic resin communication needle 24. A convex portion 27 that engages with the temporary fixing portion 26 is provided. In the state where the temporary fixing portion 26 is engaged with the convex portion 27, the distal end portion of the synthetic resin communication needle 24 is set to be held at a position away from the diaphragm 22.

次いで、図6に示す可撓性液剤容器51と図2に示す薬剤容器1とからなる薬剤混合装置50を製造する手順について説明する。尚、可撓性液剤容器51は、液剤が収容されてオートクレーブ滅菌されている。
可撓性液剤容器51と薬剤容器1は各容器の表面を紫外線照射等により滅菌処理を行い無菌組立て装置内に搬送される。可撓性液剤容器51の連結口部材21の接続ポート23には滅菌キャップ(図示せず)が液密に装着された状態でオートクレーブ滅菌されているので、薬剤容器1の接続筒13と嵌合する直前で滅菌キャップを取り除くまでは接続ポート23は無菌状態が保たれている。
Next, a procedure for manufacturing the medicine mixing device 50 including the flexible liquid medicine container 51 shown in FIG. 6 and the medicine container 1 shown in FIG. 2 will be described. The flexible liquid container 51 contains a liquid and is autoclaved.
The flexible liquid container 51 and the medicine container 1 are sterilized by ultraviolet irradiation or the like on the surface of each container, and are conveyed into the aseptic assembly apparatus. The connection port 23 of the connection port member 21 of the flexible liquid container 51 is autoclaved with a sterilization cap (not shown) attached in a liquid-tight manner, and therefore is fitted to the connection tube 13 of the drug container 1. Until the sterilization cap is removed immediately before the connection, the connection port 23 remains in a sterile state.

また、図2に示す薬剤容器1の連結口組立体10は上述したように樹脂キャップ7により密封されているので、可撓性液剤容器51の接続ポート23と嵌合する直前で図4に示すように樹脂キャップ7を取り除くまでは無菌状態を保たれている。このようにして、可撓性液剤容器51の連結口部材21と薬剤容器1の接続筒13とが無菌状態で嵌合固定される。接続筒13の小径部13aには孔部14が形成されており、連結口部材21の爪部23cをこの孔部14に引っ掛けて接続筒13と連結口部材21は固定される。このため、接続筒13内は無菌状態を確実に維持することができ、また、薬剤容器1の懸垂口部3で薬剤混合装置50を吊下げる場合であっても、可撓性液剤容器51を確実に保持することができる。  2 is sealed by the resin cap 7 as described above, and is shown in FIG. 4 just before fitting with the connection port 23 of the flexible liquid agent container 51. Thus, the sterility is maintained until the resin cap 7 is removed. In this manner, the connection port member 21 of the flexible liquid container 51 and the connection tube 13 of the drug container 1 are fitted and fixed in a sterile state. A hole 14 is formed in the small-diameter portion 13a of the connection tube 13, and the connection tube 13 and the connection port member 21 are fixed by hooking the claw portion 23c of the connection port member 21 into the hole 14. For this reason, the inside of the connecting tube 13 can be reliably maintained in a sterilized state, and even when the drug mixing device 50 is suspended by the suspension port 3 of the drug container 1, the flexible liquid drug container 51 is provided. It can be held securely.

また、接続筒13と連結口部材21を同じ熱可塑性樹脂で成形すれば、爪部23cを加熱溶融させて爪部23cと接続筒13を溶着させることができる。この場合、更に強く接続筒13と連結口部材21が固定される。  Moreover, if the connection cylinder 13 and the connection port member 21 are shape | molded with the same thermoplastic resin, the nail | claw part 23c can be heat-melted and the nail | claw part 23c and the connection cylinder 13 can be welded. In this case, the connection cylinder 13 and the connection port member 21 are more firmly fixed.

また、本実施の形態では、可撓性液剤容器51と薬剤容器1を確実に液密に接続できるように接続パッキン12を用いている。接続パッキン12はドーナツ状の平板であり、内側の空間には連結口部材21の接続ポート23の先端部23aが挿入される。接続パッキン12の内側の空間の内径は、接続ポート23の先端部23aの外径よりも小さくしてあるので、接続パッキン12と接続ポート23は液密に嵌合することができる。  Moreover, in this Embodiment, the connection packing 12 is used so that the flexible liquid container 51 and the chemical | medical agent container 1 can be connected liquid-tightly reliably. The connection packing 12 is a donut-shaped flat plate, and the distal end portion 23a of the connection port 23 of the connection port member 21 is inserted into the inner space. Since the inner diameter of the space inside the connection packing 12 is smaller than the outer diameter of the tip 23a of the connection port 23, the connection packing 12 and the connection port 23 can be fitted in a liquid-tight manner.

また、本実施の形態では、接続ポート23の基端部23bが接続筒13の小径部13aに嵌合するように構成されているため、可撓性液剤容器51と薬剤容器1との接続をより確実なものとしている。これにより、接続ポート23と接続筒13とが略一直線状に一体化するため、合成樹脂製連通針24を薬剤容器1の方向へスライドさせる際の作業性が向上する。  Further, in the present embodiment, since the base end portion 23b of the connection port 23 is configured to fit into the small diameter portion 13a of the connection cylinder 13, the connection between the flexible liquid agent container 51 and the drug container 1 is established. It is more certain. Thereby, since the connection port 23 and the connection cylinder 13 are integrated in a substantially straight line, the workability when the synthetic resin communication needle 24 is slid in the direction of the medicine container 1 is improved.

次に、図8及び図9に基づいて、本発明の薬剤混合装置50が合成樹脂製連通針24により連通される状態を説明する。
図8は図5に示す薬剤混合装置の全体を示す部分断面図、図9は図5に示す薬剤混合装置の連通状態を示す部分断面図である。
まず、可撓性液剤容器51越しの操作により合成樹脂製連通針24のフランジ24bを連結口部材21側にスライドさせる。そうすると、合成樹脂製連通針24の先端は連結口部材の隔膜22を突き破る。さらに、フランジ24bを連結口部材21側にスライドさせると、合成樹脂製連通針24の先端は、薬剤容器1の内キャップ11を貫通し、薬剤容器1の薬剤容器本体2の内部と可撓性液剤容器51の液剤容器本体52の内部が合成樹脂製連通針24の連通孔24aを介して連通状態になる。
Next, based on FIG.8 and FIG.9, the state which the chemical | medical agent mixing apparatus 50 of this invention is connected by the synthetic resin communication needle 24 is demonstrated.
FIG. 8 is a partial cross-sectional view showing the entirety of the drug mixing apparatus shown in FIG. 5, and FIG. 9 is a partial cross-sectional view showing a communication state of the drug mixing apparatus shown in FIG.
First, the flange 24b of the synthetic resin communication needle 24 is slid to the connection port member 21 side by an operation through the flexible liquid container 51. Then, the tip of the synthetic resin communication needle 24 breaks through the diaphragm 22 of the connection port member. Further, when the flange 24b is slid toward the connecting port member 21, the tip of the synthetic resin communication needle 24 penetrates the inner cap 11 of the drug container 1 and is flexible with the inside of the drug container body 2 of the drug container 1. The inside of the liquid agent container body 52 of the liquid agent container 51 is brought into a communication state via the communication hole 24 a of the synthetic resin communication needle 24.

このようにして、薬剤容器1の薬剤容器本体2の内部と可撓性液剤容器51の液剤容器本体52の内部が連通すると、薬剤容器1の薬剤容器本体2を外部から圧迫することにより薬液が合成樹脂製連通針24の連通孔24aを通って可撓性液剤容器51内に流入する。全ての薬液が可撓性液剤容器52内に流入した後、希釈液と混合される。そして、ゴム栓体58に輸液セットなどを接続して患者に混合薬剤が投与される。  Thus, when the inside of the medicine container body 2 of the medicine container 1 and the inside of the liquid medicine container body 52 of the flexible liquid medicine container 51 communicate with each other, the medicine liquid is pressed by pressing the medicine container body 2 of the medicine container 1 from the outside. It flows into the flexible liquid agent container 51 through the communication hole 24 a of the synthetic resin communication needle 24. After all the chemical liquid flows into the flexible liquid container 52, it is mixed with the diluent. Then, an infusion set or the like is connected to the rubber plug 58 and the mixed drug is administered to the patient.

本発明は前記実施の形態に限定されるものではなく、その要旨を逸脱しない範囲で種々変更可能であることは言うまでもない。たとえば、図1に示す薬剤容器は、その外形は円筒形状に限られず、四角柱形状、六角柱形状などの角形状、あるいは扁平な楕円形状としても良い。また、樹脂キャップも前記実施の形態の形状に限定されるものではなく、その形状は任意である。  It goes without saying that the present invention is not limited to the above-described embodiment, and various modifications can be made without departing from the scope of the invention. For example, the outer shape of the drug container shown in FIG. 1 is not limited to a cylindrical shape, but may be a square shape such as a quadrangular prism shape or a hexagonal prism shape, or a flat elliptical shape. Also, the resin cap is not limited to the shape of the above embodiment, and the shape is arbitrary.

本発明の一実施の形態に係る薬剤容器の全体を示す平面図である。  It is a top view which shows the whole chemical | medical agent container which concerns on one embodiment of this invention. 図1に示す薬剤容器の部分断面図である。  It is a fragmentary sectional view of the medicine container shown in FIG. 図1に示す薬剤容器の製造工程を示す部分断面図である。  It is a fragmentary sectional view which shows the manufacturing process of the chemical | medical agent container shown in FIG. 図1に示す薬剤容器の樹脂キャップを捻じ切ったところを示す部分断面図である。  It is a fragmentary sectional view which shows the place which twisted off the resin cap of the chemical | medical agent container shown in FIG. 図4に示す薬剤容器を用いた薬剤混合装置の全体を示す平面図である。  It is a top view which shows the whole chemical | medical agent mixing apparatus using the chemical | medical agent container shown in FIG. 図5に示す薬剤混合装置を構成する可撓性液剤容器の全体を示す平面図である。  It is a top view which shows the whole flexible liquid agent container which comprises the chemical | medical agent mixing apparatus shown in FIG. 図6に示す可撓性液剤容器の拡大部分断面図である。  It is an expanded partial sectional view of the flexible liquid agent container shown in FIG. 図5に示す薬剤混合装置の全体を示す部分断面図である。  It is a fragmentary sectional view which shows the whole chemical | medical agent mixing apparatus shown in FIG. 図5に示す薬剤混合装置の連通状態を示す部分断面図である。  It is a fragmentary sectional view which shows the communication state of the chemical | medical agent mixing apparatus shown in FIG.

符号の説明Explanation of symbols

1 薬剤容器
2 薬剤容器本体
3 懸垂口部
4 固定部
5 上部開口部
7 樹脂キャップ
10 第1の接続手段(接続口組立体)
11 内キャップ(蓋体)
12 接続パッキン
13 絶縁筒
13a 小径部
13b 大径部
14 孔部(係合手段)
20 第2の接続手段
21 連結口部材
22 隔膜
23 接続ポート
23a 先端部
23b 基端部
23c 爪部(係合手段)
24 合成樹脂製連通針
24a 連通孔
24b フランジ
50 薬剤混合装置
51 可撓性液剤容器
52 液剤容器本体
100 中空成形金型
101 供給ノズル
102 金型
DESCRIPTION OF SYMBOLS 1 Drug container 2 Drug container main body 3 Hanging part 4 Fixing part 5 Upper opening part 7 Resin cap 10 1st connection means (connection port assembly)
11 Inner cap (lid)
12 connection packing 13 insulating cylinder 13a small diameter part 13b large diameter part 14 hole (engagement means)
20 2nd connection means 21 Connecting port member 22 Diaphragm 23 Connection port 23a Tip part 23b Base end part 23c Claw part (engagement means)
24 Synthetic Resin Communication Needle 24a Communication Hole 24b Flange 50 Drug Mixing Device 51 Flexible Liquid Agent Container 52 Liquid Agent Container Body 100 Hollow Molding Mold 101 Supply Nozzle 102 Mold

Claims (13)

使用時に薬剤容器本体内に収容された薬剤を液剤と混合するための接続手段を有する薬剤容器において、
熱可塑性樹脂の成形により前記薬剤容器本体が形成され、前記薬剤容器本体の形成直後に前記薬剤容器本体内に薬剤が充填され、前記薬剤の充填直後に前記薬剤容器本体の開口部に前記接続手段を配設し、前記熱可塑性樹脂の一部を前記接続手段に溶着して前記薬剤容器本体の開口部を密閉するとともに、前記接続手段を前記熱可塑性樹脂の一部から構成される樹脂キャップで密封したことを特徴とする薬剤容器。
In a drug container having a connecting means for mixing a drug contained in a drug container main body with a liquid at the time of use,
The medicine container body is formed by molding a thermoplastic resin, the medicine container body is filled immediately after the medicine container body is formed, and the connecting means is connected to the opening of the medicine container body immediately after the medicine is filled. A resin cap composed of a part of the thermoplastic resin, and a portion of the thermoplastic resin is welded to the connecting means to seal the opening of the drug container body. A drug container characterized by being sealed.
前記接続手段は、前記薬剤容器本体を密閉する蓋体と、液剤容器の接続ポートが液密に嵌合する接続体とを有することを特徴とする請求項1に記載の薬剤容器。  The drug container according to claim 1, wherein the connecting means includes a lid that seals the drug container main body, and a connection body in which a connection port of the liquid drug container fits in a liquid tight manner. 前記蓋体と前記接続体とが同一部材からなることを特徴とする請求項2に記載の薬剤容器。  The medicine container according to claim 2, wherein the lid and the connection body are made of the same member. 前記接続手段は、一端側に前記蓋体と前記接続体が収容され、他端側に前記接続ポートが挿入される接続筒を有することを特徴とする請求項2又は3に記載の薬剤容器。  The drug container according to claim 2 or 3, wherein the connection means includes a connection cylinder in which the lid and the connection body are accommodated on one end side, and the connection port is inserted on the other end side. 前記蓋体、前記接続体及び前記接続筒とが予め一体化されており、前記熱可塑性樹脂の一部は前記接続筒に溶着していることを特徴とする請求項4に記載の薬剤容器。  The drug container according to claim 4, wherein the lid, the connection body, and the connection cylinder are integrated in advance, and a part of the thermoplastic resin is welded to the connection cylinder. 前記接続ポートの先端部と前記接続体とが同軸的に嵌合し、前記接続ポートの基端部と前記接続筒とが同軸的に嵌合し、前記接続体の内径が前記接続筒の内径よりも小さいことを特徴とする請求項4又は5に記載の薬剤容器。  The distal end portion of the connection port and the connection body are fitted coaxially, the proximal end portion of the connection port and the connection tube are fitted coaxially, and the inner diameter of the connection body is the inner diameter of the connection tube The medicine container according to claim 4 or 5, wherein the medicine container is smaller. 前記接続筒の内周面と前記接続ポートの基端部外周面とに相互に係合する係合手段を設けたことを特徴とする請求項4乃至6のいずれか一に記載の薬剤容器。  The medicine container according to any one of claims 4 to 6, further comprising engagement means for engaging the inner peripheral surface of the connection tube and the outer peripheral surface of the proximal end portion of the connection port. 前記係合手段は、一方が爪部で他方が孔部であることを特徴とする請求項7に記載の薬剤容器。  8. The drug container according to claim 7, wherein one of the engaging means is a claw portion and the other is a hole portion. 前記薬剤容器本体の非開口部に懸垂口部を設けたことを特徴とする請求項1乃至8のいずれか一に記載の薬剤容器。  The drug container according to any one of claims 1 to 8, wherein a suspension opening is provided in a non-opening portion of the drug container main body. 使用時に薬剤容器本体内に収容された薬剤を液剤と混合するための接続手段を有する薬剤容器の製造方法において、
熱可塑性樹脂をブロー成形又は真空成形して前記薬剤容器本体を形成する第1の工程と、
前記ブロー成形又は真空成形直後に前記薬剤容器本体内に薬剤を充填する第2の工程と、
前記薬剤の充填直後に前記薬剤容器本体の開口部に前記接続手段を配設する第3の工程と、
前記熱可塑性樹脂の一部を前記接続手段に溶着して前記薬剤容器本体の開口部を密閉する第4の工程と、
前記熱可塑性樹脂の一部を前記接続手段を覆うようにして樹脂キャップを形成する第5の工程と
を備えたことを特徴とする薬剤容器の製造方法。
In the method of manufacturing a drug container having a connection means for mixing the drug contained in the drug container body with the liquid at the time of use,
A first step of blow molding or vacuum forming a thermoplastic resin to form the drug container body;
A second step of filling the drug container body with a drug immediately after the blow molding or vacuum molding;
A third step of disposing the connecting means at the opening of the drug container body immediately after the filling of the drug;
A fourth step of welding a part of the thermoplastic resin to the connecting means and sealing the opening of the drug container body;
And a fifth step of forming a resin cap so that a part of the thermoplastic resin covers the connecting means.
前記接続手段は、前記薬剤容器本体を密閉する蓋体と、液剤容器の接続ポートが液密に嵌合する接続体と、前記接続ポートが挿入される接続筒とを有し、前記蓋体、前記接続体及び前記接続筒とが予め一体化されているとともに、前記熱可塑性樹脂の一部は前記接続筒に溶着していることを特徴とする請求項10に記載の薬剤容器の製造方法。  The connection means includes a lid for sealing the drug container body, a connection body in which a connection port of a liquid medicine container is fitted in a liquid-tight manner, and a connection cylinder into which the connection port is inserted, the lid body, The method for producing a drug container according to claim 10, wherein the connection body and the connection cylinder are integrated in advance, and a part of the thermoplastic resin is welded to the connection cylinder. 熱可塑性樹脂の成形により形成される薬剤容器本体を有し、前記薬剤容器本体の形成直後に前記薬剤容器本体内に薬剤が充填され、前記薬剤の充填直後に前記薬剤容器本体の開口部に第1の接続手段を配設し、前記熱可塑性樹脂の一部を前記第1の接続手段に溶着して前記薬剤容器本体の開口部を密閉するとともに、前記熱可塑性樹脂の一部で構成される樹脂キャップで前記第1の接続手段を密封してなる薬剤容器と、
連結直前に前記樹脂キャップが除去された前記第1の接続手段と接続される第2の接続手段を有し、液剤容器本体内に液剤が収容された液剤容器とを備え
使用時に前記第1の接続手段と前記第2の接続手段とを介して前記薬剤容器本体内と前記液剤容器本体内とが連通可能となるように構成したことを特徴とする薬剤混合装置。
It has a medicine container body formed by molding a thermoplastic resin, the medicine container body is filled with the medicine immediately after the medicine container body is formed, and immediately after the medicine is filled, the opening is formed in the opening of the medicine container body. 1 connection means is disposed, and a part of the thermoplastic resin is welded to the first connection means to seal the opening of the drug container body, and the thermoplastic resin part is constituted by a part of the thermoplastic resin. A drug container in which the first connecting means is sealed with a resin cap;
And a second liquid connection container connected to the first connection means from which the resin cap has been removed immediately before connection, and a liquid agent container containing a liquid agent in a liquid agent container body. A drug mixing apparatus, wherein the drug container main body and the liquid drug container main body can communicate with each other via a connection means and the second connection means.
前記第1の接続手段は、前記薬剤容器本体を密閉する蓋体と、前記第2の接続手段を構成する接続ポートが液密に嵌合する接続体と、一端側に前記蓋体と前記接続体とが収容され、他端側に前記接続ポートが挿入される接続筒とを有し、
前記第2の接続手段は、前記接続ポートと、前記接続ポートに設けられ、前記液剤容器本体内を外部と遮蔽する隔膜と、前記接続ポート内に配設され、内部に軸方向の液体流路が形成された連通針とを有し、
前記連通針は、保管時にその先端が前記隔膜と離間した位置に保持され、使用時にその先端が前記隔膜及び前記蓋体を穿通する位置まで移動可能とされ、前記連通針の前記液体流路を介して前記薬剤が前記液剤容器本体内に流入可能とされていることを特徴とする請求項12に記載の薬剤混合装置。
The first connection means includes a lid for sealing the drug container body, a connection body in which a connection port constituting the second connection means is fitted in a liquid-tight manner, and the lid and the connection on one end side. And a connecting cylinder into which the connection port is inserted on the other end side,
The second connection means is provided in the connection port, a diaphragm provided in the connection port and shields the inside of the liquid container body from the outside, and disposed in the connection port, and an axial liquid flow path therein. And a communication needle formed,
The communicating needle is held at a position where the tip is separated from the diaphragm during storage, and the tip is movable to a position where it penetrates the diaphragm and the lid during use, and the communicating needle passes through the liquid flow path of the communicating needle. The drug mixing device according to claim 12, wherein the drug is allowed to flow into the liquid drug container body.
JP2003358482A 2003-09-10 2003-09-10 Drug container, its manufacturing method, and drug mixing apparatus Pending JP2005081124A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003358482A JP2005081124A (en) 2003-09-10 2003-09-10 Drug container, its manufacturing method, and drug mixing apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003358482A JP2005081124A (en) 2003-09-10 2003-09-10 Drug container, its manufacturing method, and drug mixing apparatus

Publications (1)

Publication Number Publication Date
JP2005081124A true JP2005081124A (en) 2005-03-31

Family

ID=34420039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003358482A Pending JP2005081124A (en) 2003-09-10 2003-09-10 Drug container, its manufacturing method, and drug mixing apparatus

Country Status (1)

Country Link
JP (1) JP2005081124A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007111114A (en) * 2005-10-18 2007-05-10 Canon Inc Liquid discharge device and liquid discharge cartridge for use in same discharge device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007111114A (en) * 2005-10-18 2007-05-10 Canon Inc Liquid discharge device and liquid discharge cartridge for use in same discharge device
US8146586B2 (en) 2005-10-18 2012-04-03 Canon Kabushiki Kaisha Liquid ejection cartridge and liquid ejection device

Similar Documents

Publication Publication Date Title
US5380315A (en) Mixing apparatus
EP0079326B1 (en) Fluid transfer assembly
JPH10180791A (en) Manufacture of filling syringe body of plastic for medical treatment
JP2001522280A (en) Sterile connector
KR20140125793A (en) Multiple dose vial and method
JPH07116224A (en) Syringe
JP2011177588A (en) Container with hollow needle
JP2002224195A (en) Transfusion container
JP2008521532A (en) New device
US20230248957A1 (en) System comprising a cap for a medical fluid container and an attachment part, medical fluid container, and method for producing a fluid container
PH12014502543B1 (en) Needle-equipped connecting member, and drug dissolution kit
JP2005081124A (en) Drug container, its manufacturing method, and drug mixing apparatus
JP2005013681A (en) Drug receptacle, its manufacturing method and drug mixing device
JPH07171192A (en) Infusion vessel
CN106074160A (en) The infusion vessel dispenser that can the most directly join and infusion vessel
JP2004141601A (en) Two-medicinal liquid mixer
JP3834158B2 (en) Multi-chamber container
JP3210573B2 (en) Method for forming thin film at mouth of synthetic resin container for infusion
EP4082600A1 (en) Valve, method of manufacturing a valve, cap for a fluid container comprising such valve, fluid container containing such cap, and method for manufacturing such cap
JP2580793Y2 (en) Pressure-resistant holder for container and syringe
JPH11104213A (en) Cap for medicine container
WO2022229334A1 (en) Cap for a fluid container, fluid container comprising such cap and method for manufacturing such cap
JPH0928765A (en) Mouth part structure for medical container and assembling method therefor
JPH0717311Y2 (en) Chemical solution container
JPH08332225A (en) Syringe